메뉴 건너뛰기
American Journal of Pediatric Hematology/Oncology
Volumn 22, Issue 4, 2000, Pages 360-362
Acute stroke-like encephalopathy associated with high-dose methotrexate impurities
Author keywords

[No Author keywords available]
Indexed keywords

BICARBONATE; FOLINIC ACID; METHOTREXATE;
EID: 0034455554     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200007000-00017     Document Type: Letter
Times cited : (8)
References (11)
  • 1
    • 0028294651 scopus 로고
    • Neurotoxicity secondary to antineoplastic drugs.
    • Tuxen MK, Hanson SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev 1994;20:191-214.
    • (1994) Cancer Treat Rev , vol.20 , pp. 191-214
    • Tuxen, M.K.1    Hanson, S.W.2
  • 2
    • 0021930911 scopus 로고
    • Transient neurologic disturbances induced by highdose methotrexate treatment.
    • Jaffe N, Takaue Y, Anzai T, et al. Transient neurologic disturbances induced by highdose methotrexate treatment. Cancer 1985;56:1356-60.
    • (1985) Cancer , vol.56 , pp. 1356-60
    • Jaffe, N.1    Takaue, Y.2    Anzai, T.3
  • 3
    • 0022880320 scopus 로고
    • Transient cerebral dysfunction secondary to highdose methotrexate.
    • Walker RW, Allen JC, Rosen G, et al. Transient cerebral dysfunction secondary to highdose methotrexate. J Clin Oncol 1986;4:1845-50.
    • (1986) J Clin Oncol , vol.4 , pp. 1845-50
    • Walker, R.W.1    Allen, J.C.2    Rosen, G.3
  • 4
    • 0020612730 scopus 로고
    • High dose systemic methotrexate associated acute neurologic dysfunction.
    • Packer RJ, Grossman RI, Belasco JB. High dose systemic methotrexate associated acute neurologic dysfunction. Med Pediatr Oncol 1983;11:159-61.
    • (1983) Med Pediatr Oncol , vol.11 , pp. 159-61
    • Packer, R.J.1    Grossman, R.I.2    Belasco, J.B.3
  • 5
    • 0005504687 scopus 로고
    • Transient encephalopathy during the late course of treatment with highdose methotrexate.
    • Fritsch G, Urban C. Transient encephalopathy during the late course of treatment with highdose methotrexate. Cancer Treat Rep 1982;66:1719-22.
    • (1982) Cancer Treat Rep , vol.66 , pp. 1719-22
    • Fritsch, G.1    Urban, C.2
  • 6
    • 0017964837 scopus 로고
    • Transient cerebral dysfunction following chemotherapy for osteogenoc sarcoma.
    • Allen JC, Rosen G. Transient cerebral dysfunction following chemotherapy for osteogenoc sarcoma. Ann Neurol 1978;3:441-4.
    • (1978) Ann Neurol , vol.3 , pp. 441-4
    • Allen, J.C.1    Rosen, G.2
  • 7
    • 0021864108 scopus 로고
    • CNS toxicity of dihydrofolate reductase (DGFR) inhibitors is not due to effects of tetradrobiopterin (BH') synthesis abstract.
    • Duch DS, Bowers SW, Reinhard JF, et al. CNS toxicity of dihydrofolate reductase (DGFR) inhibitors is not due to effects of tetradrobiopterin (BH') synthesis [abstract]. Proc Am Assoc Cancer Res 1985;26:235.
    • (1985) Proc Am Assoc Cancer Res , vol.26 , pp. 235
    • Duch, D.S.1    Bowers, S.W.2    Reinhard, J.F.3
  • 8
    • 0005504388 scopus 로고
    • Effect of intravenous highdose methotrexate (IVHDMTX) on regional cerebral glucose metabolic rate (rCMRGlu) in the rat abstract.
    • Phillips PC, Allen J, Rottenberg DA, et al. Effect of intravenous highdose methotrexate (IVHDMTX) on regional cerebral glucose metabolic rate (rCMRGlu) in the rat [abstract]. Proc Am Assoc Cancer Res 1985;26:371.
    • (1985) Proc Am Assoc Cancer Res , vol.26 , pp. 371
    • Phillips, P.C.1    Allen, J.2    Rottenberg, D.A.3
  • 9
    • 0017884023 scopus 로고
    • Identification and quantitation of impurities in methotrexate.
    • Chatterji DC, Frazier AG, Gallelli JF. Identification and quantitation of impurities in methotrexate. J Pharm Sci 1978;67:622-4.
    • (1978) J Pharm Sci , vol.67 , pp. 622-4
    • Chatterji, D.C.1    Frazier, A.G.2    Gallelli, J.F.3
  • 10
    • 0018144402 scopus 로고
    • Analysis of methotrexate and 7-hydroxymethotrexate by highpressure liquid chromatography.
    • Wisnicki JL, Tong WP, Ludlum DB. Analysis of methotrexate and 7-hydroxymethotrexate by highpressure liquid chromatography. Cancer Treat Rep 1978;62:529-32.
    • (1978) Cancer Treat Rep , vol.62 , pp. 529-32
    • Wisnicki, J.L.1    Tong, W.P.2    Ludlum, D.B.3
  • 11
    • 0017836348 scopus 로고
    • Separation and identification of impurities in parenteral methotrexate dosage forms.
    • Hignite CE, Shen DD, Azarnoff D. Separation and identification of impurities in parenteral methotrexate dosage forms. Cancer Treat Rep 1978;62:1318.
    • (1978) Cancer Treat Rep , vol.62 , pp. 1318
    • Hignite, C.E.1    Shen, D.D.2    Azarnoff, D.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.